These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 475375)

  • 41. Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model.
    Neumann-Haefelin D; Sundmacher R; Skoda R; Cantell K
    Infect Immun; 1977 Aug; 17(2):468-70. PubMed ID: 408274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon induced in human leukocytes by mitogens: production, partial purification and characterization.
    de Ley M; van Damme J; Claeys H; Weening H; Heine JW; Billiau A; Vermylen C; de Somer P
    Eur J Immunol; 1980 Nov; 10(11):877-83. PubMed ID: 6161829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensitivity of rhinoviruses to human leukocyte and fibroblast interferons.
    Came PE; Schafer TW; Silver GH
    J Infect Dis; 1976 Jun; 133 Suppl():A136-9. PubMed ID: 180194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Administration of human fibroblast interferon in chronic hepatitis-B infection.
    Desmyter J; De Groote J; Desmet VJ; Billiau A; Ray MB; Bradburne AF; Edy VG; De Somer P
    Lancet; 1976 Sep; 2(7987):645-7. PubMed ID: 60513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon: mechanisms of action and clinical value.
    Houglum JE
    Clin Pharm; 1983; 2(1):20-8. PubMed ID: 6192965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon administered in the cerebrospinal space and its effect on rabies in rabbits.
    Ho M; Nash C; Morgan CW; Armstrong JA; Carroll RG; Postic B
    Infect Immun; 1974 Feb; 9(2):286-93. PubMed ID: 4816460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon-induced skin reactivity in man.
    De Somer P; Edy VG; Billiau A
    Lancet; 1977 Jul; 2(8027):47-8. PubMed ID: 69141
    [No Abstract]   [Full Text] [Related]  

  • 48. Circulating interferon in man after administration of exogenous human leukocyte interferon.
    Emödi G; Just M; Hernandez R; Hirt HR
    J Natl Cancer Inst; 1975 May; 54(5):1045-9. PubMed ID: 1127735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.
    Vilcek J; Sulea IT; Zerebeckyj IL; Yip YK
    J Clin Microbiol; 1980 Jan; 11(1):102-5. PubMed ID: 7354125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation between fever and interferon titer in rabbits after induction with myxoviruses.
    Siegert R; Shu HL; Kohlhage H
    Life Sci; 1967 Mar; 6(6):615-20. PubMed ID: 6034178
    [No Abstract]   [Full Text] [Related]  

  • 51. Production, purification and clinical application of human fibroblast interferon.
    Carter WA; Horoszewicz JS
    Pharmacol Ther; 1980; 8(2):359-77. PubMed ID: 6155675
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of the suppression of cell and virus growth in transformed human cells of leukocyte and fibroblast interferon.
    Kuwata T; Fuse A; Suzuki N; Morinaga N
    J Gen Virol; 1979 May; 43(2):435-9. PubMed ID: 225426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is interferon tissue specific?- Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines.
    Einhorn S; Strander H
    J Gen Virol; 1977 Jun; 35(3):573-7. PubMed ID: 267737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease.
    Priestman TJ
    Lancet; 1980 Jul; 2(8186):113-8. PubMed ID: 6157064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating interferon in rabbits and monkeys after administration of human gamma interferon by different routes.
    Cantell K; Hirvonen S; Pyhälä L; De Reus A; Schellekens H
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1823-6. PubMed ID: 6409993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of routes of administration of interferon in cancer: a review and a proposal.
    Bocci V
    Cancer Drug Deliv; 1984; 1(4):337-51. PubMed ID: 6085757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impossibility of defining unequivocally the antiviral activity of human fibroblast interferon in terms of a human leukocyte interferon standard.
    Hilfenhaus F
    J Biol Stand; 1978; 6(2):159-64. PubMed ID: 649623
    [No Abstract]   [Full Text] [Related]  

  • 58. Partial purification of human interferon by affinity chromatography.
    Anfinsen CB; Bose S; Corley L; Gurari-Rotman D
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3139-42. PubMed ID: 4370251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferon responses in maternal and fetal mice.
    Evans AT; Carandang G; Quilligan EJ; Cesario TC
    Am J Obstet Gynecol; 1985 May; 152(1):99-102. PubMed ID: 2581450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography.
    Jankowski WJ; Davey MW; O'Malley JA; Sulkowski E; Carter WA
    J Virol; 1975 Nov; 16(5):1124-30. PubMed ID: 1185850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.